Furthermore, numerous studies have identified aberrant glycosylation patterns in AD-associated proteins such as amyloid precursor protein (APP), tau, beta-secretase 1 (BACE1), and nicastrin (NCSTN), highlighting the potential for N-glycan biomarkers in early AD diagnosis [108,165]. This evidence concerns the gene NCSTN and Alzheimer disease.